Improving Outcomes in Prostate and Renal Cell Carcinomas 2010
May 29, 2010(Ended)
Moscone Center
San Francisco, CA, United States
San Francisco, CA, United States
This educational activity has been developed to provide medical
oncologists, radiation oncologists, surgeons, urologists, and other
healthcare professionals with a comprehensive overview of recent
advances in the management of prostate and renal cell cancers.At the conclusion of this activity, participants should be able to:
- List therapeutic approaches to optimize outcomes for patients with advanced prostate cancer, including the importance of managing bone metastases
- Compare and contrast traditional chemotherapies with novel chemotherapeutic agents in the management of patients with castration-resistant prostate cancer
- Discuss the rationale and evaluate the clinical utility of biomarkers to guide the therapeutic decision-making process in patients with renal cell carcinoma
- Describe current management strategies utilizing targeted therapies for patients with metastatic renal cell carcinoma based on prognostic risk stratification and toxicity-related issues
Venue
Address
747 Howard Street,
San Francisco,
California,
United States
San Francisco,
California,
United States
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Health conferences
- Medical Seminars for All in the Field
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters.
- Corneal endothelial recovery in patients undergoing small incision cataract surgery comparison between diabetics and non diabetics.
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters
